Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
12 | 123399523 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
12 | 123383447 | upstream gene variant | G/A;C;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms | 0.030 | 0.667 | 3 | 2016 | 2019 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms | 0.020 | 0.500 | 2 | 2018 | 2019 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||||
|
1.000 | 0.120 | 12 | 123389469 | missense variant | C/T | snv | 1.4E-05 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.120 | 12 | 123389469 | missense variant | C/T | snv | 1.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.689 | 0.360 | 12 | 123409283 | 3 prime UTR variant | C/G;T | snv |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |